Profil
Phillip Altman is the founder of Pharmaco Pty Ltd., ARCS Australia Ltd.
He worked as a Non-Executive Director at Viralytics Pty Ltd.
from 2009 to 2014.
Altman received his undergraduate, graduate, and doctorate degrees from The University of Sydney.
Postes actifs de Phillip Altman
| Sociétés | Poste | Début |
|---|---|---|
| ARCS Australia Ltd. | Fondateur | 10/12/2010 |
Anciens postes connus de Phillip Altman
| Sociétés | Poste | Fin |
|---|---|---|
| VIRALYTICS LTD. | Directeur/Membre du Conseil | 01/09/2014 |
| Pharmaco Pty Ltd. | Fondateur | - |
Formation de Phillip Altman
| The University of Sydney | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
| Pharmaco Pty Ltd. | |
| ARCS Australia Ltd. |
